Community-reported insights only, not medical advice. Data recency varies by source; check timestamps and confidence before making treatment decisions.

← Back to Brands

Therismos Access 7:8

Community footprint analysis based on portfolio size and patient feedback.

Time Period:
Rank
15
Portfolio
1 Strain
Mentions (90d)
1
Brand Score (90d)
70
vs Market Avg: 63 vs All Time: 65
Performing Well

Rating higher than the 90d community baseline.

Medication Portfolio (1)

Rank Strain Name Specs Mentions (90d) Score (90d) Historical Avg
73
7.0%
2
66
65